Childhood Hodgkin's disease in Uganda: a ten year experience

Cancer. 1978 Aug;42(2):787-92. doi: 10.1002/1097-0142(197808)42:2<787::aid-cncr2820420251>3.0.co;2-4.

Abstract

Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available. Thirty-eight percent had early stage disease (stages I-IIIA). Prolonged first remissions were achieved in 74% of 42 complete responders. Of 11 patients who relapsed, 5 had prolonged second remissions induced by MOPP. Three patients were lost to follow-up and 15 of the remaining 45 died: 12 of these from progressive Hodgkin's disease, 2 from unrelated causes and 1 from Burkitt's lymphoma after 4 months remission from Hodgkin's disease. Acturial survival for all patients is 67% (75% for stages I-IIIA and 60% for stages IIIB-IV). Treatment complications included Herpes zoster and gynaecomastia. The latter is probably related to gonadal dysfunction. All stages of childhood Hodgkin's disease can be successfully managed with MOPP chemotherapy alone.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Gynecomastia / etiology
  • Herpes Zoster / etiology
  • Hodgkin Disease / complications
  • Hodgkin Disease / drug therapy*
  • Humans
  • Infant
  • Lomustine / therapeutic use
  • Male
  • Mechlorethamine / therapeutic use
  • Prednisone / therapeutic use
  • Procarbazine / therapeutic use
  • Recurrence
  • Remission, Spontaneous
  • Time Factors
  • Uganda
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Lomustine
  • Prednisone